Pacer Advisors Portfolio holdings
AUM
$39.6B
1-Year Return
5.04%
This Quarter Return
+7.06%
1 Year Return
+5.04%
3 Year Return
+42.86%
5 Year Return
+91.64%
10 Year Return
+332.32%
AUM
$2.66B
AUM Growth
+$447M
(+20%)
Cap. Flow
+$326M
Cap. Flow
% of AUM
12.28%
Top 10 Holdings %
Top 10 Hldgs %
18.05%
Holding
1,341
New
172
Increased
969
Reduced
51
Closed
109
Top Buys
| 1 |
Amazon
AMZN
|
+$20.2M |
| 2 |
Microsoft
MSFT
|
+$14.2M |
| 3 |
Apple
AAPL
|
+$13.2M |
| 4 |
Exxon Mobil
XOM
|
+$7.75M |
| 5 |
PepsiCo
PEP
|
+$7.11M |
Top Sells
| 1 |
BF
BASF AKTIENGESELLT ADS(RP1 ORD
BF
|
+$7.2M |
| 2 |
Medtronic
MDT
|
+$5.4M |
| 3 |
Accenture
ACN
|
+$4.98M |
| 4 |
Schlumberger
SLB
|
+$4.33M |
| 5 |
LyondellBasell Industries
LYB
|
+$4.25M |
Sector Composition
| 1 | Technology | 21.38% |
| 2 | Healthcare | 13.82% |
| 3 | Consumer Discretionary | 11.89% |
| 4 | Financials | 11.87% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEWR
976
DELISTED
New Relic, Inc.
NEWR
| $256K | 0.01% |
+2,716
| New | +$256K |
|
|
LOXO
977
DELISTED
Loxo Oncology, Inc
LOXO
| $255K | 0.01% |
+1,492
| New | +$255K |
|
978
Buckle
BKE
$3.04B
| $253K | 0.01% |
10,973
+7,684
| +234% | +$177K |
|
979
Amicus Therapeutics
FOLD
$2.46B
| $252K | 0.01% |
+20,810
| New | +$252K |
|
|
ARNA
980
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $252K | 0.01% |
+5,473
| New | +$252K |
|
981
Gannett
GCI
$610M
| $251K | 0.01% |
16,024
+11,155
| +229% | +$175K |
|
982
Puma Biotechnology
PBYI
$230M
| $251K | 0.01% |
+5,468
| New | +$251K |
|
|
MGLN
983
DELISTED
Magellan Health Services, Inc.
MGLN
| $249K | 0.01% |
3,449
+1,601
| +87% | +$116K |
|
|
CSOD
984
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $249K | 0.01% |
+4,385
| New | +$249K |
|
985
FibroGen
FGEN
$45.1M
| $246K | 0.01% |
+162
| New | +$246K |
|
|
SRCL
986
DELISTED
Stericycle Inc
SRCL
| $245K | 0.01% |
4,175
+510
| +14% | +$29.9K |
|
|
BLUE
987
DELISTED
bluebird bio
BLUE
| $244K | 0.01% |
+129
| New | +$244K |
|
988
Under Armour
UAA
$2.19B
| $241K | 0.01% |
11,346
+2,697
| +31% | +$57.3K |
|
989
Box
BOX
$4.8B
| $240K | 0.01% |
+10,041
| New | +$240K |
|
990
Tredegar Corp
TG
$274M
| $240K | 0.01% |
11,095
+8,834
| +391% | +$191K |
|
991
MaxLinear
MXL
$1.38B
| $239K | 0.01% |
+12,033
| New | +$239K |
|
992
Editas Medicine
EDIT
$251M
| $237K | 0.01% |
+7,434
| New | +$237K |
|
|
P
993
DELISTED
Pandora Media Inc
P
| $237K | 0.01% |
+24,954
| New | +$237K |
|
994
Myriad Genetics
MYGN
$643M
| $236K | 0.01% |
+5,140
| New | +$236K |
|
995
Mativ Holdings
MATV
$680M
| $234K | 0.01% |
6,105
+4,017
| +192% | +$154K |
|
|
SAGE
996
DELISTED
Sage Therapeutics
SAGE
| $233K | 0.01% |
+1,653
| New | +$233K |
|
997
Tenaris
TS
$18.2B
| $232K | 0.01% |
6,918
-2,249
| -25% | -$75.4K |
|
998
Alnylam Pharmaceuticals
ALNY
$59.6B
| $231K | 0.01% |
+2,640
| New | +$231K |
|
999
Madrigal Pharmaceuticals
MDGL
$10.1B
| $231K | 0.01% |
+1,078
| New | +$231K |
|
1000
Enanta Pharmaceuticals
ENTA
$190M
| $230K | 0.01% |
+2,693
| New | +$230K |
|